Tavo Biotherapeutics
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $17M
Investors
- 3
About Tavo Biotherapeutics
Tavo Biotherapeutics, Inc. specializes in creating therapies for glaucoma and retinal conditions. Founded in 2024, the company is headquartered in Laguna Beach, US. Tavo Biotherapeutics specializes in the development of innovative therapies targeting glaucoma and retinal diseases. Their flagship product, TAV-001, operates through three primary mechanisms: it reduces intraocular pressure by modulating autonomic signaling, enhances ocular perfusion as a vasodilator, and provides neuroprotection by dampening glutamate release, thus mitigating excitotoxicity and inflammation leading to vision loss. The company is expected to collaborate with healthcare providers, hospitals, and research institutions for the distribution and application of their therapies, particularly TAV-001, once commercially available. Their revenue model focuses on direct contracts with healthcare entities involved in therapeutic solutions and clinical studies, with anticipated revenue streams closely tied to the successful commercialization of their products. In June 2026, Tavo Biotherapeutics, Inc.
Who invested in Tavo Biotherapeutics
3 investors across 1 round
See all investors in Tavo Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 2, 2026
Amount
$17M
Investors
Questions about Tavo Biotherapeutics
Who invested in Tavo Biotherapeutics?
Tavo Biotherapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tavo Biotherapeutics raised?
Tavo Biotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tavo Biotherapeutics last raise money?
Tavo Biotherapeutics's most recent round on record is a Series A, in Jun 2026.
What does Tavo Biotherapeutics do?
Tavo Biotherapeutics is a biotechnology company.
Where is Tavo Biotherapeutics headquartered?
Tavo Biotherapeutics is headquartered in Laguna Beach, US.
Which VCs invest in companies like Tavo Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tavo Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tavo Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.